Production of active MMP7 in E. coli and its application for metalloproteinase inhibitors screening

Protein and Peptide Letters

Volumn 17, Issue 5, 2010, Pages 568-572

  Katsuno, H ^a   Shirakawa, R ^a   Miyazaki, K ^a   Ozeki, Y ^a   Yasumitsu, H ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

GST fusion; Matrix metalloproteinase; Metalloproteinase inhibitor; MMP 7 matrilysin; Reverse zymography; Soluble expression in E. coli

Indexed keywords

ENZYME INHIBITOR; GLUTATHIONE; MATRILYSIN; MMP7 PROTEIN, HUMAN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; BIOSYNTHESIS; CHEMISTRY; DRUG ANTAGONISM; ENZYMOLOGY; ESCHERICHIA COLI; GENETICS; HUMAN; METABOLISM; METHODOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; TUMOR CELL LINE;

CELL LINE, TUMOR; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME INHIBITORS; ESCHERICHIA COLI; GLUTATHIONE; HUMANS; MATRIX METALLOPROTEINASE 7; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 77952006105     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986610791112648     Document Type: Article

References (27)

1. Hooper, N.M. Zinc metalloproteinases in health and disease. Taylor & Francis, London, United Kingdom, 1996.
2. Murphy, G.; Nagase, H. Progress in matrix metalloproteinase research. Mol. Aspects Med., 2008, 29, 290-308.
3. Wielockx, B.; Libert, C.; Wilson, C. Matrilysin (matrix metlloproteinase-7): a new promising drug target in cancer and inflammation? Cytokine Growth Factor Rev., 2004, 15, 111-115.
4. Yokoyama, Y.; Grunebach, F.; Schmidt, S.M.; Hiene, A.; Hantschel, M.; Stevanovic, S.; Rammensee, H.-G.; Brossart, P. Matrilysin (mmp-7) is a novel broadly expressed tumor antigen recognized by antigen-specific T cells. Clin. Cancer Res., 2008, 14, 5503-5511.
5. Nilsson, L.; Jonasson, L.; Nijm, J.; Hamsten, A.; Eriksson, P. Increased plasma concentration of matrix metalloproteinase-7 in patients with coronary artery disease. Clin. Chem., 2006, 52, 1522-1527.
6. Acar, A.; Onan, A.; Coskun, U.; Uner, A.; Bagriacik, U.; Atalay, F.; Unsal, D.K.; Guner, H. Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer. Med. Oncol., 2008, 2, 279-283.
7. Kuhlmann, K.F.; van Till, J.W.; Boermeester, M.A.; de Reuver, P.R.; Tzvetanova, I.D.; Offerhaus, G.J.; Ten Kate, F.J.; Busch, O.R.; van Gulik, T.M.; Gouma, D.J.; Crawford, H.C. Evaluation of matrix metalloproteinase 7 in plasma and pancreatic juice as a biomarker for pancreatic cancer. Cancer Epidemiol. Biomarkers Prev., 2007, 16, 886-891.
8. Maurel, J.; Nadal, C.; Garcia-Albeniz, X.; Gallego, R.; Carcereny, E.; Almendro, V.; Marmol, M.; Gallardo, E.; Maria Auge, J.; Longaron, R.; Martinez-Fernandez, A.; Molina, R.; Castells, A.; Gascon, P. Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients. Int. J. Cancer, 2007, 121, 1066-1071.
9. Ramankulov, A.; Lein, M.; Johannsen, M.; Schrader, M.; Miller, K.; Jung, K. Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinomas. Cancer Sci., 2008, 99, 1188-1194.
10. Sarkissian, G.; Fergelot, P.; Lamy, P.J.; Patard, J.J.; Culine, S.; Jouin, P.; Rioux-Leclercq, N.; Darbouret, B. Identification of pro-MMP-7 as a serum marker for renal cell carcinoma by use of proteomic analysis. Clin. Chem., 2008, 54, 574-581.
11. Voorzanger-Rousselot, N.; Juillet, F.; Mareau, E.; Zimmermann, J.; Kalebic, T.; Garnero, P. Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluation. Br. J. Cancer, 2006, 95, 506-514.
12. Crabbe, T.; Willenbrock, F.; Eaton, D.; Hynds, P.; Carne, A.F.; Murphy, G.; Docherty, A.J. Biochemical characterization of matrilysin. Activation conforms to the stepwise mechanisms proposed for other matrix metalloproteinases. Biochemistry, 1992, 31, 8500-8507.
13. Barnett, J.; Straub, K.; Nguyen, B.; Chow, J.; Suttman, R.; Thompson, K.; Tsing, S.; Benton, P.; Schatzman, R.; Chen, M. et al. Production, purification, and characterization of human matrilysin (PUMP) from recombinant Chinese hamster ovary cells. Protein Expr. Purif., 1994, 5, 27-36.
14. Lopez de Turiso, J.A.; Fernandez, P.; Barbacid, M.M.; Mira, E.; Quesada, A.R.; Marquez, G.; Aracil, M. Expression and purification of human matrilysin produced in baculovirus-infected insect cells. J. Biotechnol., 1996, 46, 235-241.
15. Welch, A.R.; Holman, C.M.; Browner, M.F.; Gehring, M.R.; Kan, C.C.; Van Wart, H.E. Purification of human matrilysin produced in Escherichia coli and characterization using a new optimized fluorogenic peptide substrate. Arch. Biochem. Biophys., 1995, 324, 59-64.
16. Kihira, Y.; Mori, K.; Miyazaki, K.; Matuo, Y. Production of recombinant human matrix metalloproteinase 7 (matirlysin) with potential role in tumor invasion by refolding from Esherichia coli inclusion bodies and development of sandwich ELISA of MMP-7. Urol. Oncol., 1996, 2, 20-26.
17. Cha, J.; Pedersen, M.V.; Auld, D.S. Metal and pH dependence of heptapeptide catalysis by human matrilysin. Biochemistry, 1996, 35, 15831-15838.
18. Itoh, M.; Masuda, K.; Ito, Y.; Akizawa, T.; Yoshioka, M.; Imai, K.; Okada, Y.; Sato, H.; Seiki, M. Purification and refolding of recombinant human proMMP-7 (pro-matrilysin) expressed in Escherichia coli and its characterization. J. Biochem., 1996, 119, 667-673.
19. Oneda, H.; Inouye, K., Refolding and recovery of recombinant human matrix metalloproteinase 7 (matrilysin) from inclusion bodies expressed by Escherichia coli. J. Biochem., 1999, 126, 905-911.
20. Ou, L.; Ma, J.; Zheng, X.; Chen, X.; Li, G.; Wu, H., The expression and refolding of isotopically labeled recombinant Matrilysin for NMR studies. Protein Expr. Purif., 2006, 47, 367-373.
21. Soler, D.; Nomizu, T.; Brown, W.E.; Chen, M.; Ye, Q.Z.; Van Wart, H.E.; Auld, D.S., Zinc content of promatrilysin, matrilysin and the stromelysin catalytic domain. Biochem. Biophys. Res. Commun., 1994, 201, 917-923.
22. Soler, D.; Nomizu, T.; Brown, W.E.; Shibata, Y.; Auld, D.S., Matrilysin: expression, purification, and characterization. J. Protein Chem., 1995, 14, 511-520.
23. Yamamoto, K.; Higashi, S.; Kioi, M.; Tsunezumi, J.; Honke, K.; Miyazaki, K., Binding of active matrilysin to cell surface cholesterol sulfate is essential for its membrane-associated proteolytic action and induction of homotypic cell adhesion. J. Biol. Chem. 2006, 281, 9170-9180.
24. Miyata, S.; Koshikawa, N.; Yasumitsu, H.; Miyazaki, K., Trypsin stimulates integrin alpha(5)beta(1)-dependent adhesion to fibronectin and proliferation of human gastric carcinoma cells through activation of proteinase-activated receptor-2. J. Biol. Chem., 2000, 275, 4592-4598.
25. Miyazaki, K.; Hattori, Y.; Umenishi, F.; Yasumitsu, H.; Umeda, M., Purification and characterization of extracellular matrix-degrading metalloproteinase, matrin (pump-1), secreted from human rectal carcinoma cell line. Cancer Res., 1990, 50, 7758-7764.
26. Miyazaki, K.; Funahashi, K.; Numata, Y.; Koshikawa, N.; Akaogi, K.; Kikkawa, Y.; Yasumitsu, H.; Umeda, M., Purification and characterization of a two-chain form of tissue inhibitor of metalloproteinases (TIMP) type 2 and a low molecular weight TIMP-like protein. J. Biol. Chem., 1993, 268, 14387-14393.
27. nd ed., Elsevier, 2004.